Purinergic and nitrergic neurotransmission predominantly mediate inhibitory neuromuscular transmission in the rat colon. We studied the sensitivity of both purinergic and nitrergic pathways to spadin, a TWIK-related potassium channel 1 (TREK1) inhibitor, apamin, a small-conductance calcium-activated potassium channel blocker and 1H- [1, 2, 4] oxadiazolo [4,3-␣]quinoxalin-1-one (ODQ), a specific inhibitor of soluble guanylate cyclase. TREK1 expression was detected by RT-PCR in the rat colon. Patch-clamp experiments were performed on cells expressing hTREK1 channels. Spadin (1 M) reduced currents 1) in basal conditions 2) activated by stretch, and 3) with arachidonic acid (AA; 10 M). L-Methionine (1 mM) or L-cysteine (1 mM) did not modify currents activated by AA. Microelectrode and muscle bath studies were performed on rat colon samples. L-Methionine (2 mM), apamin (1 M), ODQ (10 M), and N -nitro-L-arginine (L-NNA; 1 mM) depolarized smooth muscle cells and increased motility. These effects were not observed with spadin (1 M). Purinergic and nitrergic inhibitory junction potentials (IJP) were studied by incubating the tissue with L-NNA (1 mM) or MRS2500 (1 M). Both purinergic and nitrergic IJP were unaffected by spadin. Apamin reduced both IJP with a different potency and maximal effect for each. ODQ concentration dependently abolished nitrergic IJP without affecting purinergic IJP. Similar effects were observed in hyperpolarizations induced by sodium nitroprusside (1 M) and nitrergic relaxations induced by electrical stimulation. We propose a pharmacological approach to characterize the pathways and function of purinergic and nitrergic neurotransmission. Nitrergic neurotransmission, which is mediated by cyclic guanosine monophosphate, is insensitive to spadin, an effective TREK1 channel inhibitor. Both purinergic and nitrergic neurotransmission are inhibited by apamin but with different relative sensitivity. apamin; spadin; ODQ; smooth muscle; gastrointestinal INHIBITORY NEUROMUSCULAR TRANSMISSION in the gastrointestinal tract is predominantly mediated by ATP (or a related purine) and nitric oxide (NO). Neural release of these inhibitory neurotransmitters causes an inhibitory junction potential (IJP) with two phases: a fast (IJPf) followed by a slow (IJPs) component (6, 17). The purinergic pathway involves the activation of P2Y 1 receptors, which are responsible for the IJPf (12). P2Y 1 antagonists MRS2179, MRS2279, and MRS2500 have helped in the characterization of purinergic IJP (10, 12, 15) , recently confirmed with P2Y 1 knocked-out mice (11, 19) . In contrast, the IJPs is NO mediated and inhibited by 34) . Using this pharmacological approach, we have recently characterized inhibitory neural tone in the rat colon. In this tissue, ongoing neural release of NO maintains a certain degree of smooth muscle hyperpolarization and consequently tissue incubation with N -nitro-L-arginine (L-NNA) causes smooth muscle depolarization and increases spontaneous motility. In contrast, neural release of purines causes "spontaneous" IJP that are sensitive to P2Y 1 antagonists (13).
Purinergic and nitrergic neurotransmission predominantly mediate inhibitory neuromuscular transmission in the rat colon. We studied the sensitivity of both purinergic and nitrergic pathways to spadin, a TWIK-related potassium channel 1 (TREK1) inhibitor, apamin, a small-conductance calcium-activated potassium channel blocker and 1H- [1, 2, 4] oxadiazolo [4,3-␣] quinoxalin-1-one (ODQ), a specific inhibitor of soluble guanylate cyclase. TREK1 expression was detected by RT-PCR in the rat colon. Patch-clamp experiments were performed on cells expressing hTREK1 channels. Spadin (1 M) reduced currents 1) in basal conditions 2) activated by stretch, and 3) with arachidonic acid (AA; 10 M). L-Methionine (1 mM) or L-cysteine (1 mM) did not modify currents activated by AA. Microelectrode and muscle bath studies were performed on rat colon samples. L-Methionine (2 mM), apamin (1 M), ODQ (10 M) , and N -nitro-L-arginine (L-NNA; 1 mM) depolarized smooth muscle cells and increased motility. These effects were not observed with spadin (1 M). Purinergic and nitrergic inhibitory junction potentials (IJP) were studied by incubating the tissue with L-NNA (1 mM) or MRS2500 (1 M). Both purinergic and nitrergic IJP were unaffected by spadin. Apamin reduced both IJP with a different potency and maximal effect for each. ODQ concentration dependently abolished nitrergic IJP without affecting purinergic IJP. Similar effects were observed in hyperpolarizations induced by sodium nitroprusside (1 M) and nitrergic relaxations induced by electrical stimulation. We propose a pharmacological approach to characterize the pathways and function of purinergic and nitrergic neurotransmission. Nitrergic neurotransmission, which is mediated by cyclic guanosine monophosphate, is insensitive to spadin, an effective TREK1 channel inhibitor. Both purinergic and nitrergic neurotransmission are inhibited by apamin but with different relative sensitivity. apamin; spadin; ODQ; smooth muscle; gastrointestinal INHIBITORY NEUROMUSCULAR TRANSMISSION in the gastrointestinal tract is predominantly mediated by ATP (or a related purine) and nitric oxide (NO). Neural release of these inhibitory neurotransmitters causes an inhibitory junction potential (IJP) with two phases: a fast (IJPf) followed by a slow (IJPs) component (6, 17) . The purinergic pathway involves the activation of P2Y 1 receptors, which are responsible for the IJPf (12) . P2Y 1 antagonists MRS2179, MRS2279, and MRS2500 have helped in the characterization of purinergic IJP (10, 12, 15) , recently confirmed with P2Y 1 knocked-out mice (11, 19) . In contrast, the IJPs is NO mediated and inhibited by L-NNA (23, 34) . Using this pharmacological approach, we have recently characterized inhibitory neural tone in the rat colon. In this tissue, ongoing neural release of NO maintains a certain degree of smooth muscle hyperpolarization and consequently tissue incubation with N -nitro-L-arginine (L-NNA) causes smooth muscle depolarization and increases spontaneous motility. In contrast, neural release of purines causes "spontaneous" IJP that are sensitive to P2Y 1 antagonists (13) .
Apamin is a pharmacological tool widely used to discriminate between the fast and the slow component of the IJP and even nowadays the term "apamin sensitive" vs. "apamin insensitive" IJP is often used in the literature. Apamin reduces the IJPf in several areas of the gastrointestinal tract and in several species (22, 38, 39, 43, 46, 49) . However, the slow component is also partially reduced by apamin in the human colon (23) and smallconductance calcium-activated potassium channel (SK Ca ) channels might participate in nitrergic neurotransmission in the ileum of the hamster (28) and in the esophagus of the opossum where the junction potential is mainly nitrergic (5) . These data suggest that SK Ca channels might be involved in both purinergic and nitrergic neurotransmission, but the relative sensitivity to apamin in purinergic and nitrergic pathways is unknown.
Stretch-dependent potassium (SDK) channels have been described in murine colonic smooth muscle cells (25) . SDK channels are activated by NO donors and cGMP analogs, suggesting that they can transduce nitrergic signals (25) . SDK channels have similar properties to TWIK-related potassium (TREK) channels, a two-pore-domain potassium channel (K2P or KCNK) subgroup (37) . TREK channels (TREK1, TREK2, and TRAAK) might be important in the regulation of smooth muscle functions. In particular, TREK1 channels are expressed in murine antrum, fundus, jejunum, and colon (24) . TREK1 channels are activated by stretch and might participate in the adaptation of the gastrointestinal tract to content by inducing smooth muscle hyperpolarization and relaxation in regions with reservoir functions. Moreover, it has been shown that sodium nitroprusside (SNP) and 8-Br-cGMP (an analog of cGMP) increased TREK1 currents in COS cells (24) . These findings suggest that TREK1 channels might mediate nitrergic neurotransmission in smooth muscle cells, but this is a controversial issue. The NO/cGMP/PKG pathway did not activate K2P channels in vascular smooth muscle (27) , and L-methionine, a putative TREK1 channel blocker, did not modify the nitrergic IJP in the lower esophageal sphincter, suggesting that TREK1 channels do not mediate nitrergic neurotransmission (47) .
The lack of specific agonists and antagonists has complicated the investigation of the role of TREK1 channels. Sulfur-containing amino acids, particularly L-methionine, inhibit SDK channels and reduce IJPs in the murine colon (33) . High concentrations (mM range) of L-methionine, however, are needed to inhibit TREK1 channels expressed in COS cells (3) . Moreover, nonspecific effects are also possible since sulfur-containing amino acids are involved in the transsulfuration pathway (41) as well as in the synthesis of hydrogen sulfide (14, 21) . Recently, spadin, a sortilin-derived peptide, was shown to inhibit murine and human TREK1 channels expressed in COS cells at nanomolar concentrations (29, 32) . This compound binds specifically to murine TREK1 channels with an affinity of ϳ10 nM (29) and does not block TREK2, TRAAK, TASK1, TRESK, IKr, or IKS currents (32) . Furthermore, spadin acts as an antidepressant in mice, and this effect is not observed in TREK1-deficient mice (kcnk2
) showing that it is specifically mediated by TREK1 channel inhibition (29) . Spadin is thus an interesting pharmacological tool to investigate the putative involvement of TREK1 channels in the regulation of colonic motility.
In the present study we characterized the nitrergic and purinergic neurotransmission to study the mechanisms responsible for each pathway with special relevance to the putative effects of spadin, a specific TREK1 channel inhibitor (29, 31, 32) .
MATERIALS AND METHODS

Animals and Tissue Samples
Male Sprague-Dawley rats (8 -10 wk old, 300 -350 g) were purchased from Charles River (Lyon, France). Animals were housed under controlled conditions: temperature 22 Ϯ 2°C, humidity 55 Ϯ 10%, 12:12-h light-dark cycle and access to water and food ad libitum. Animals were stunned and killed by decapitation and exsanguination 2-3 s afterward. The colon was quickly removed and placed in carbogenated (95% O 2-5% CO2), ice-cold physiological saline solution. Then it was opened along the mesenteric border and pinned to a Sylgard base (mucosa side up). The mid colon was identified accordingly to anatomical criteria previously described (2) . The mucosal and submucosal layers were removed and muscle strips were cut (1 cm ϫ 0.3 cm) for the intracellular microelectrode and organ bath experiments. All procedures were approved by the Ethics Committee of the Universitat Autònoma de Barcelona.
Real-Time Quantitative PCR Analysis
Total RNA (5 g) from rat brain and colon was used for reverse transcription reaction carried out with the Superscript II reverse transcriptase (Invitrogen, Cergy Pontoise, France) according to the protocol of the supplier. Real-time PCR analysis (SYBR Green Mastermix, Roche, Meylan, France) was performed to estimate the level of expression of TREK1 in both tissues. The results were normalized with the endogenous reference cyclophilin D (CycloD). Real-time PCR assays (triplicate for each target gene tested) were performed in 96 well-plates on a Roche 480 Lightcycler apparatus. Data were analyzed by the comparative Cp method where the amount of target was normalized to the endogenous reference (User Bulletin no. 2, Applied Biosystems). Primers used for the different amplicons were as follows: TREK1 forward TTTTCCTGGTG-GTCGTCCTC; TREK1 reverse GCTGCTCCAATGCCTTGAAC; CycloD forward GGCTCTTGAAATGGACCCTTC; CycloD reverse CAGCCAATGCTTGATCATATTCTT.
Cell Culture
COS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum in an atmosphere of 95% air-5% CO 2. The culture medium was completed with 1% (vol/vol) of penicillin-streptomycin and GlutaMAX ϫ 1 (both from Invitrogen, Cergy Pontoise, France).
hTREK1/HEK cells were cultured in DMEM, 1% penicillin-streptomycin, 1% GlutaMAX, 0.5 mg/ml G418, FBS 10%.
Patch-Clamp Studies in Cells Expressing hTREK1 Channels
Electrophysiological experiments were performed on COS-7 cells seeded at a density of 20,000 cells/35-mm dish, 24 h before transfection. Cells were transfected by the JetPEI method as described by the manufacturer's protocol (Ozyme, Saint-Quentin-en-Yvelines, France). COS-7 cells were transfected with 25 ng of hTREK1 pIRES-2-eGFP vector and cells were measured 48 -72 h after transfection. The whole cell patch-clamp technique was used to evaluate TREK1 potassium currents. Each current was recorded using a RK 400 patch-clamp amplifier (Axon Instruments, Foster City, CA), low-pass filtered at 3 kHz, and digitized at 10 kHz by use of a 12-bit analog-to-digital converter (Digidata 1322 series, Axon Instruments). Patch-clamp pipettes were pulled by use of a vertical puller (PC-10, Narishige, Tokyo, Japan) from borosilicate glass capillaries and had resistances of 3-5 M⍀. All experiments were performed at room temperature (21-22°C). Except for excised patch-clamp experiments in the stretch protocol, TREK1 currents were recorded in the presence of a cocktail of potassium channel inhibitors [K ϩ blockers: 3 mM 4-aminopyridine (4-AP), 10 mM tetraethylammonium (TEA), 10 M glibenclamide, 100 nM apamin, and 50 nM charybdotoxin]. Stimulation protocols and data acquisition were carried out via a microcomputer (Dell Pentium) that used commercial software and hardware (pClamp 8.2). TREK1 currents were recorded from Ϫ100 to ϩ60 mV membrane potentials in 20-mV steps applied from a holding potential of Ϫ80 mV. Duration of depolarization pulses were 0.825 ms and the pulse cycling rate was 5 s. TREK1 current amplitudes were evaluated at the end of the stimulation pulses. Cells were continuously superfused with microperfusion system. L-Cysteine 1 mM, L-methionine 1 mM, and spadin 1 M were tested on hTREK1 current. All current amplitudes are expressed in current densities (pA/pF).
For stretch experiments, patch-clamp measurements were performed on hTREK1/HEK cells constitutively expressing hTREK1 (31) . Cells were used 2 to 4 days after plating with 50 000 cells per dish. All electrophysiological recordings were performed at room temperature in inside-out mode. Patch pipettes of ϳ1.5 M⍀ were used. Membrane patches were stimulated with negative pressure pulses, from 0 to Ϫ40 mmHg in Ϫ10 mmHg increments during 300 ms each 3 s, through the recording electrode using a pressure-clamp device (ALA High Speed Pressure Clamp-1 system; ALA Scientific Instruments, Farmingdale, NY). Holding potential was maintained at 0 mV. Spadin was used at 1 M. For all experiments, currents were filtered at 1 kHz, digitized at 20 kHz, and analyzed with pCLAMP 9.2 and ORIGIN 6.0 (Rithm Informatique, Paris, France) software.
Intracellular Microelectrode Recording in the Rat Colon
The tissue was pinned with the circular muscle layer facing upward in a Sylgard-coated chamber, continuously perfused with carbogenated physiological saline solution at 37 Ϯ 1°C, and allowed to equilibrate for 1 h. Circular smooth muscle cells were impaled with glass microelectrodes filled with 3 M KCl (30 -60 M⍀ of resistance). Membrane potential was measured by using standard electrometer Duo773 (WPI, Sarasota, FL). Tracings were displayed on an oscilloscope 4026 (Racal-Dana, Windsor, UK) and simultaneously digitalized (100 Hz) with PowerLab 4/30 system and Chart 5 software for Windows (both from AD Instruments, Castle Hill, NSW, Australia). Experiments were performed in the presence of nifedipine (1 M) to stabilize impalements.
Estimation of RMP and sIJP. The spontaneous inhibitory neural tone was characterized as we have described previously (13) . Briefly, the resting membrane potential (RMP; expressed in mV) was estimated as the most probable bin of the frequency distribution of the membrane potential (0.1-mV bins; 30 -60 s recordings). Spontaneous inhibitory junction potentials (sIJP) were evaluated by calculating the mean standard deviation (SD) of the distribution of the membrane potential: SD of the recording inside the cell minus SD of the recording outside the cell (expressed in mV).
EFS elicited IJP. As previously described (9), IJP were also elicited by electrical field stimulation (EFS) by using the following parameters: 1) Single pulses, pulse duration 0.3 ms, and increasing amplitude voltage (8, 12, 16, 20, 24, 28, 32, 36 and 40 V) . 2) In addition, train stimuli of 5-s duration were also performed at 1 Hz (5 pulses) and 5 Hz (25 pulses) at supramaximal voltages (32 V) and pulse duration 0.3 ms.
Purinergic IJP were evaluated in the presence of L-NNA (1 mM) by use of single pulses elicited at supramaximal voltages. In contrast, nitrergic IJP were evaluated in the presence of MRS2500 (1 M) by using train pulses of 5 Hz elicited at supramaximal voltages. The amplitude of these IJP was measured from the RMP to the most hyperpolarized value and expressed in mV.
Muscle Bath Studies in the Rat Colon
Muscle strips were mounted in a 10-ml organ bath containing carbogenated physiological saline solution maintained at 37 Ϯ 1°C. Motility was measured via an isometric force transducer (Harvard VF-1 Harvard Apparatus, Holliston, MA) connected to a computer through an amplifier. Data were digitized (25 Hz) by using Data 2001 software (Panlab, Barcelona, Spain) coupled to an analog-to-digital converter installed in the computer. A tension of 1 g was applied and tissues were allowed to equilibrate for 1 h after which strips displayed spontaneous phasic activity. To test the stretch sensitivity of the mechanism, different stretch (from 1 to 4 g) were applied in steps of 1 g. EFS was applied after 30 min for each step of stretch. The release of inhibitory neurotransmitters was studied by using EFS applied for 4 min, pulse duration 0.3 ms, frequency 5 Hz, amplitude 30 V. The area under the curve (AUC) of contractions from the baseline was measured to estimate the mechanical activity and the result was expressed in grams per minute (g/min). The basal tone, expressed in grams, was measured in stretch experiments.
Solutions and Drugs
The composition of the physiological saline solution was (in mM) 10.10 glucose, 115.48 NaCl, 21.90 NaHCO3, 4.61 KCl, 1.14 NaH2PO4, 2.50 CaCl 2, and 1.16 MgSO4 (pH 7.3-7.4). In all the experiments, phentolamine, atropine, and propranolol (1 M) were added to the physiological saline solution to block ␣-and ␤-adrenoceptors and muscarinic receptors. 
Data Analysis and Statistics
To normalize mechanical data, EFS-induced relaxation was calculated as percentage of inhibition by use of the following formula: 1 Ϫ[AUC during EFS/AUC previous EFS] ϫ 100. Note that a complete cessation of spontaneous motility means 100% inhibition while 0% is a complete blockade of the inhibitory response observed during EFS. Negative data indicate a larger contractile activity during EFS than the one observed prior EFS.
For electrophysiological experiments on COS-7 cells, statistical analysis of differences between groups was performed by using unpaired t-test. For electrophysiological experiments on hTREK1/ HEK cells, significance was tested with a permutation test (R Development Core Team: http://www.r-project.org/) for n Ͻ 30. Differences in the resting membrane potential, sIJP, purinergic and nitrergic IJP, spontaneous motility (AUC), and hyperpolarizations induced by SNP were compared before and after drug addition by a paired Student's t-test. One-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test was used to compare the effect of the different drugs on EFS-induced relaxation. Two-way ANOVA followed by Bonferroni's multiple comparison test was performed to evaluate the effect of spadin on EFS-induced relaxation at different levels of tension. IC50 were calculated by using a conventional sigmoid concentration-response curve with variable slope.
Data are expressed as means Ϯ SE; n values indicate the number of samples. A P Ͻ 0.05 was considered statistically significant. Statis- 
RESULTS
TREK1 Channel Expression in the Rat Colon
Real-time quantitative RT-PCR analysis revealed that TREK1 channel mRNA is expressed in the rat colon, although mRNA expression in the colon was ϳ27-fold lower than in the brain (Fig. 1) .
Effect of L-Methionine, L-Cysteine, and Spadin on TREK1 Channel Activity
Human TREK1 channels expressed in COS-7 cells displayed a relatively weak current. The basal current was reduced by spadin (1 M) (Fig. 2B) . AA (10 M) was used to amplify the current. Note that AA (10 M) did not cause any effect when tested in nontransfected COS-7 cells (data not shown). The contribution of other potassium channels was blocked with the use of a K ϩ channel inhibitory cocktail (K ϩ blockers). In these experimental conditions, neither L-Cys (1 mM) (Fig. 2, A and B) nor L-methionine (1 mM) (Fig. 2 , C and D) affected the AA (10 M)-activated hTREK1 currents that, as previously demonstrated, were inhibited by spadin (1 M) (29) (Fig. 2, A-D) . Stretch applied by increasing negative pressure pulses increased currents in hTREK1/HEK cells constitutively expressing hTREK1 channels. Spadin (1 M) inhibited ϳ50% stretch-induced currents (n ϭ 12; Fig. 3 ). Therefore, spadin is a suitable TREK1 channel inhibitor for further studies concerning the implication of these channels in the purinergic and nitrergic neurotransmission process.
Resting Membrane Potential and Spontaneous Motility
Despite the fact that TREK1 channel expression was detected in the rat colon, spadin (1 M) did not modify smooth muscle membrane potential or mechanical activity (Table 1; Fig. 4A ). However, apamin (1 M), ODQ (10 M), L-NNA (1 mM), and L-methionine (1 mM) depolarized the smooth muscle cells and increased mechanical activity (Table 1 ; Fig. 4 , B-E). 
Spontaneous Inhibitory Junction Potentials
Spontaneous IJP (sIJP) were recorded in samples of rat mid colon (0.77 Ϯ 0.09 mV SD; n ϭ 13). Spadin (1 M) did not modify sIJP (control: 0.67 Ϯ 0.04 mV vs. spadin 1 M: 0.65 Ϯ 0.07 mV SD; n ϭ 4; not significant). Despite causing smooth muscle depolarization, neither ODQ (10 M) nor L-methionine (1 mM) produced significant changes in sIJP (for ODQ, control: 0.71 Ϯ 0.18 mV vs. ODQ 10 M: 0.65 Ϯ 0.10 mV SD; n ϭ 5; not significant; and for Table 2 ). 
Effect of Spadin, Apamin, ODQ, and L-Methionine on EFSInduced IJP
Single-pulse stimulation elicited an IJPf followed by an IJPs (Fig. 5, A-C) . Train pulses at 1 Hz (supramaximal voltage during 5 s) induced five consecutive hyperpolarizations whereas at 5 Hz they elicited a hyperpolarization characterized by a fast component followed by a more sustained one (Fig. 5,  B and C) . Similar protocols have been used to characterize the junction potential in human colon (9) .
L-NNA (1 mM) and MRS2500 (1 M) were used to isolate purinergic and nitrergic IJP, respectively. In the presence of L-NNA, the IJP was a pure purinergic IJP because it was completely abolished by the subsequent addition of MRS2500 (1 M) (Fig. 5B) . In the presence of MRS2500 (1 M), the IJP was a pure nitrergic IJP because it was completely abolished by the subsequent addition of L-NNA (1 mM) (Fig. 5C ). Singlepulse stimulation and trains of 5 Hz were used to evaluate the effect of spadin, apamin, ODQ, and L-methionine on pure purinergic and nitrergic IJP, respectively.
Neither purinergic nor nitrergic IJP were affected by spadin ( Table 2 , Fig. 6A ) but both were reduced by apamin ( (Fig. 6B) . ODQ concentration dependently inhibited nitrergic neuromuscular transmission (E max : 98.5 Ϯ 4.7%; IC 50 ϭ 8.5·10 Ϫ7 M; Table 2 ; Fig. 6C ) without affecting purinergic IJP (Table 2 ; Fig. 6C ). Finally, concentrations up to 2 mM of L-methionine did not modify purinergic or nitrergic IJP ( Table 2) .
Effect of Spadin, Apamin, ODQ, and L-Methionine on EFSInduced Nitrergic Relaxation
In organ bath experiments, blockade of P2Y 1 receptors did not modify the relaxation induced by EFS (relaxation: 99.9 Ϯ 0.1%; n ϭ 30; Fig. 7 ). In the presence of MRS2500 (1 M), EFS-induced relaxation was not reduced by spadin (1 M) (Fig. 7, A and E) but was decreased by relatively high concentrations of apamin (1 M) (Fig. 7, B and E) . ODQ (10 M) completely abolished EFS-induced relaxation and a contractile response compared with control was observed (Fig. 7, C and E). As previously described (15), EFS induced a clear contractile response in the presence of MRS2500 (1 M) and L-NNA (1 mM) compared with control (Fig. 7, D and E) . Moreover, total relaxation was observed in the presence of MRS2500 (1 M) and L-methionine (2 mM) (not shown).
Because TREK1 channels are stretch dependent, the level of stretch applied to the preparation might change their contribution to nitrergic neuromuscular transmission. To test this hypothesis, relaxations induced by EFS in the presence of MRS2500 (1 M) were evaluated at different levels of stretch (from 1 to 4 g). Stretch induced a sharp increase in tone that slowly decreased, reaching a steady state after 30 min. After each applied stretch, the tone of the preparation measured at the baseline of spontaneous contractions was higher (Fig. 8, A  and B) . Spadin (1 M) did not modify this increase in tone (Fig. 8, A and B) . Furthermore, spadin (1 M) did not reduce EFS-induced relaxation at different levels of tension (Fig. 8, A  and C) .
Effect of Spadin, Apamin, and ODQ on Exogenous Addition of Sodium Nitroprusside
Exogenous addition of SNP was used to evaluate the involvement of SK Ca and TREK1 channels on nitrergic signaling. Exogenous addition of SNP (1 M) hyperpolarized the smooth muscle cells (10.8 Ϯ 0.7 mV; n ϭ 12). In addition, Note that 100% is no drug effect (total inhibition of spontaneous motility) and 0% is a complete blockade of the inhibitory response. Negative data indicate a larger contractile activity during EFS than that observed prior to EFS. All values are means Ϯ SE. Significant differences were assessed by 1-way ANOVA, followed by Bonferroni's multiple comparison test. **P Ͻ 0.01; ***P Ͻ 0.001, significant difference from control.
SNP concentration dependently inhibited spontaneous mechanical activity in the presence of TTX (1 M) (IC 50 ϭ 25.9 nM; n ϭ 5). SNP-induced hyperpolarization was not modified by spadin (1 M) (control: 10.8 Ϯ 2.0 mV vs. spadin 1 M: 9.5 Ϯ 2.0 mV; n ϭ 4; not significant; Fig. 9A ) but was reduced in the presence of apamin (1 M) (control: 10.4 Ϯ 0.7 mV vs. apamin 1 M: 6.9 Ϯ 0.7 mV; n ϭ 4; P Ͻ 0.05; Fig. 9B ) and was blocked by ODQ (10 M) (control: 11.2 Ϯ 0.8 mV vs. ODQ 10 M: 0.9 Ϯ 0.5 mV; n ϭ 4; P Ͻ 0.01; Fig. 9C ). However, neither spadin (1 M) nor apamin (1 M) was able to reduce the inhibition of the motility produced by SNP, which was inhibited by ODQ (10 M) (data not shown).
DISCUSSION
Based on our data from the rat, mice, and human colon (9, 11-13, 15, 34) , criteria can be established to consider whether a drug is acting in nitrergic vs. purinergic pathways. To simplify the discussion, Table 3 summarizes these criteria based on our previous work. In the present study we have used MRS2500 (a P2Y 1 antagonist) to isolate the nitrergic component, to characterize the nitrergic responses, and to compare them with pure purinergic responses isolated by previous incubation with L-NNA. Two possible hypotheses describe neuromuscular transmission: 1) a direct effect of neurotransmitters on smooth muscle cells supported by the fact that direct communication between nerve and muscle has been ultrastructurally described (30) , and 2) the "intercalation" hypothesis in which another cell, an interstitial cell of Cajal (ICC) or a PDGFR␣ ϩ cell (platelet-derived growth factor receptor ␣-positive cell or fibroblast-like cell), is intercalated between inhibitory neurons and smooth muscle (4, 20, 26) . This is a controversial issue (18, 36) . ICC may mediate nitrergic neurotransmission (4, 20) and PDGFR␣ ϩ cells, which express P2Y 1 receptors and SK3 channels, may contribute to purinergic neurotransmission (26) . Taking all this into consideration, we pose the following questions: What is the effect of each drug in terms of motility? Where are the drugs acting? And what is the pathway that explains each mechanism?
ODQ depolarizes smooth muscle cells, increases motility, and blocks the slow IJP and nitrergic relaxation without a major effect on the fast IJP, sIJP, or purinergic relaxation. Therefore, ODQ effects are consistent with an inhibition of the nitrergic neuromuscular transmission (Table 3 ) that is fully dependent on cGMP pathways. Nitrergic mechanical responses have been found to be totally absent in animals with ␤1 deletion of NO-sensitive guanylate cyclase (GC) used to generate complete GCKO mice (16) . In contrast, mice with selective deletion of smooth muscle GC have functional nitrergic neurotransmission, suggesting that GC located in other cell types (ICC or PDGFR␣ ϩ cells) might mediate nitrergic responses (16) .
In the present study we detected the presence of TREK1 mRNA in the rat colon although the levels were comparatively lower than those detected in the brain. TREK1 channels are (1-4 g ). These experiments were performed in the presence of MRS2500 1 M and the response induced by EFS was L-NNA sensitive. All values are means Ϯ SE (n ϭ 5). Significant differences were assessed using 2-way ANOVA, followed by Bonferroni's multiple comparison test. expressed in smooth muscle cells and might participate in nitrergic neurotransmission (24) . However, data to the contrary have been obtained in vascular smooth muscle where TREK1 channels do not participate in NO/cGMP pathways (27) , and in the lower esophageal sphincter (LES) where putative TREK1 channel inhibitors do not modify nitrergic neurotransmission (47) . One of the main difficulties in studying the function of TREK1 channels has been the lack of available specific antagonists. Patch-clamp experiments show that spadin is a potent and specific inhibitor of the human and mouse TREK1 channel (Refs. 29, 31, 32, and present study). Spadin does not block TREK2, TRAAK, TASK1, TRESK, IKr, or IKS currents (32) . Human and rat TREK1 channels exhibit high levels of homology both at the nucleic level (90%) and at the protein level (96%). Furthermore, antidepressant effects had been described both in mice and rats (29) . This work demonstrates that spadin reduces 1) basal currents, 2) AA-amplified currents, and 3) stretch-activated currents at the micromolar range in cells expressing hTREK1 receptors. All these data point out that spadin is a valuable pharmacological tool to test mechanisms in which TREK1 channels might be involved both at cellular level or even in vivo. To our knowledge this is the first time that spadin has been tested in the gastrointestinal tract. Spadin neither increased spontaneous motility nor depolarized smooth muscle cells. Furthermore, in the presence of MRS2500, spadin did not inhibit the slow IJP or EFS-induced relaxation. In the latter, no effect was observed even when different levels of stretch were applied to the strips. These results suggest that the relative contribution of TREK1 channels in nitrergic neurotransmission is minor (Table 3) . Moreover, they are not involved in purinergic neurotransmission because neither spontaneous IJP nor EFS-induced purinergic IJP is affected by spadin.
Interestingly, L-methionine and L-cysteine are not able to inhibit TREK1 channels expressed in COS-7 cells at the millimolar range, showing that these sulfur-containing amino acids are not suitable blockers of TREK1 channels. It is important to note that L-methionine increases motility and depolarizes smooth muscle cells as has been previously reported (33, 47) ; therefore, the effect of these compounds on gastrointestinal motility is probably not related to TREK1 channel inhibition. In addition, L-methionine do not modify purinergic or nitrergic IJP, showing that the biological effects caused by this compound are not related to a modification of the inhibitory neuromuscular transmission.
Apamin has been used as a pharmacological tool to distinguish between purinergic and nitrergic neurotransmission and the terminology "apamin sensitive" to define the purinergic component vs. "apamin insensitive" to define the nitrergic is often still used in the literature. The effect of apamin suggests that SK Ca are involved in both pathways (Table 3 ) but different sensitivities were estimated. Apamin reduces the occurrence of spontaneous IJP (13, 40) and reduces the fast component of the IJP (34) , suggesting that SK Ca are involved in purinergic neurotransmission. In the present article we confirm the sensitivity of the purinergic IJP (MRS2500 sensitive) to apamin, suggesting that activation of P2Y 1 receptors (11) causes an increase in calcium that binds to calmodulin and opens SK Ca (1) . Moreover, at the micromolar range, apamin increases spontaneous motility, depolarizes smooth muscle cells, and partially inhibits the nitrergic junction potential and nitrergic mechanical relaxation. However, it is important to notice that apamin inhibits ϳ40% of the nitrergic IJP, suggesting that SK Ca channels might partially mediate nitrergic responses. The mechanism that links cGMP elevation with SK Ca activation is unknown. Thus both purinergic and nitrergic pathways partially converge in one mechanism although not necessarily in the same cell. SK Ca channels are expressed in smooth muscle (35) , ICC (8) , and PDGFR␣ ϩ cells (7, 42) , and all three cell types also express GC, suggesting the presence of redundant mechanisms in the gastrointestinal tract (16) . In addition, two subtypes of SK Ca channels (i.e., SK2 and SK3) might participate in the responses. Apamin is a poor subtype-specific SK Ca channel blocker (for review, see Refs. 1, 45) and it is hard to discriminate between SK2 and SK3 subtypes. However, SK2 are slightly more sensitive to apamin than SK3 [rat SK1 channels are insensitive to apamin (44) ]. Subtype-specific SK Ca blockers are needed to verify the relative contribution of each subtype in 
Partial reversion
No effect/Partial reversion *Based on previous data using inhibitors of P2Y1 receptors (13, 15) and P2Y1 knockout mice (11) . †These criteria should be used if an inhibitory neural tone is present in the preparation (13) . ‡A decrease in spontaneous motility might be expected if ATP is limiting pre/post junctional NO effect. §Electrical field stimulation (EFS)-induced relaxations might be reversed by P2Y1 antagonists/NO synthase inhibitors depending on the frequency of EFS (9) . purinergic and nitrergic responses. It is important to note that calcium-activated chloride channels (Cl Ca ) might also be involved in nitrergic smooth muscle hyperpolarization and relaxation (48) . The contribution of these channels in each cell subtype needs further studying.
It is important to note that apamin was able to reduce the hyperpolarization induced by exogenous addition of SNP by ϳ30% whereas spadin did not modify the response. However, neither apamin nor spadin was able to reverse the inhibitory effect induced by SNP in mechanical relaxation, suggesting that the residual hyperpolarizing response (ϳ70%) was enough to maintain smooth muscle cells hyperpolarized and that voltage-dependent calcium channels could not open. It is important to note that, if specialized areas to transduce signals are present (i.e., muscle, ICC, or PDGFR␣ ϩ cells), the exogenous addition of the neurotransmitter might not mimic exactly the endogenous release from enteric inhibitory neurons.
We conclude that, in the rat colon, isolation of the nitrergic pathway by use of a P2Y 1 antagonist allows proper characterization of nitrergic neurotransmission, which is mediated by cGMP-pathway activation. Apamin inhibited both purinergic and nitrergic IJP with a different relative sensitivity. Thus the term and pharmacological approach "apamin sensitive vs. apamin insensitive" to distinguish purinergic vs. nitrergic pathways should not be used in the cotransmission process without previous studies of sensitivity to apamin in each pathway. Spadin, a TREK1 channel inhibitor, was used for the first time in the gastrointestinal tract and demonstrated the lack of TREK1 channel involvement in both purinergic and nitrergic neurotransmission. L-Methionine effects on motility did not appear to be related to TREK1 channel inhibition.
